Oral semaglutide 7 mg and 14 mg demonstrated superior A1C and body weight reductions compared to Januvia® (sitagliptin 100 mg). Non-inferiority for oral semaglutide 3 mg for A1C reduction at 26...

Sojournix, a clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative new medicines for the treatment of women's health and neuroendocrine disorders,...

DSE Digital Signage Expo The Kiosk Manufacturer Association is happy to announce that several of its sponsors will be exhibiting next week at DSE 2019. 191 companies in total will be represented....

Canon U.S.A., Inc., a leader in digital imaging solutions, will be in attendance for Vision Expo East from Friday, March 22 through Sunday, March 24, 2019 at the Jacob Javits Center in New York...

ICF (NASDAQ: ICFI), a consulting and digital services provider, announced its participation at the Sidoti & Company Spring 2019 Conference to be held at New York Marriott Marquis, 1535 Broadway,...